Joanne Wuensch
Stock Analyst at Citi
(1.62)
# 3,324
Out of 4,371 analysts
1173
Total ratings
49.8%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Buy | $110 | $81.93 | +34.26% | 80 | Jun 3, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $23 | $14.06 | +63.58% | 3 | Jun 3, 2026 | |
| BAX Baxter International | Downgraded: Hold | $19 → $17 | $19.35 | -12.14% | 58 | May 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $87 → $70 | $48.85 | +43.30% | 75 | May 29, 2026 | |
| DXCM DexCom | Maintained: Buy | $79 → $84 | $72.59 | +15.72% | 62 | May 29, 2026 | |
| ITGR Integer Holdings | Maintained: Hold | $89 → $92 | $92.74 | -0.80% | 18 | May 29, 2026 | |
| HAE Haemonetics | Maintained: Hold | $64 → $70 | $69.85 | +0.21% | 26 | May 29, 2026 | |
| PODD Insulet | Maintained: Hold | $175 → $165 | $146.41 | +12.70% | 42 | May 29, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $95 → $93 | $86.69 | +7.28% | 60 | May 29, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $22 → $17 | $19.45 | -12.60% | 43 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.35 → $5.15 | $4.60 | +11.96% | 26 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $69 | $62.02 | +11.25% | 54 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $87.45 | +15.49% | 77 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $11 → $16 | $17.56 | -8.88% | 28 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $590 | $418.82 | +40.87% | 32 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $385 | $301.21 | +27.82% | 56 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 → $350 | $320.63 | +9.16% | 42 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $76 | $76.49 | -0.64% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 → $157 | $107.51 | +46.03% | 56 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $135 → $140 | $121.69 | +15.05% | 41 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $15.35 | +23.78% | 16 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $65 | $63.81 | +1.86% | 24 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $136 → $108 | $90.78 | +18.97% | 82 | Apr 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $285 | $228.17 | +24.91% | 59 | Apr 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $198 | $149.56 | +32.39% | 37 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.15 | $1.62 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 52.88 → CHF 54.46 | $52.08 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $194.32 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $25.69 | n/a | 2 | Sep 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 | $178.90 | n/a | 3 | Aug 8, 2014 |
Medtronic
Jun 3, 2026
Maintained: Buy
Price Target: $110
Current: $81.93
Upside: +34.26%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $23
Current: $14.06
Upside: +63.58%
Baxter International
May 29, 2026
Downgraded: Hold
Price Target: $19 → $17
Current: $19.35
Upside: -12.14%
Boston Scientific
May 29, 2026
Maintained: Buy
Price Target: $87 → $70
Current: $48.85
Upside: +43.30%
DexCom
May 29, 2026
Maintained: Buy
Price Target: $79 → $84
Current: $72.59
Upside: +15.72%
Integer Holdings
May 29, 2026
Maintained: Hold
Price Target: $89 → $92
Current: $92.74
Upside: -0.80%
Haemonetics
May 29, 2026
Maintained: Hold
Price Target: $64 → $70
Current: $69.85
Upside: +0.21%
Insulet
May 29, 2026
Maintained: Hold
Price Target: $175 → $165
Current: $146.41
Upside: +12.70%
Zimmer Biomet Holdings
May 29, 2026
Maintained: Hold
Price Target: $95 → $93
Current: $86.69
Upside: +7.28%
Tandem Diabetes Care
May 29, 2026
Maintained: Hold
Price Target: $22 → $17
Current: $19.45
Upside: -12.60%
May 29, 2026
Maintained: Hold
Price Target: $4.35 → $5.15
Current: $4.60
Upside: +11.96%
May 28, 2026
Maintained: Hold
Price Target: $80 → $69
Current: $62.02
Upside: +11.25%
May 28, 2026
Reiterated: Buy
Price Target: $101
Current: $87.45
Upside: +15.49%
May 28, 2026
Upgraded: Hold
Price Target: $11 → $16
Current: $17.56
Upside: -8.88%
May 28, 2026
Reiterated: Buy
Price Target: $590
Current: $418.82
Upside: +40.87%
May 28, 2026
Reiterated: Buy
Price Target: $385
Current: $301.21
Upside: +27.82%
May 7, 2026
Maintained: Hold
Price Target: $374 → $350
Current: $320.63
Upside: +9.16%
May 6, 2026
Rated: Hold
Price Target: $65 → $76
Current: $76.49
Upside: -0.64%
May 4, 2026
Rated: Buy
Price Target: $155 → $157
Current: $107.51
Upside: +46.03%
Apr 30, 2026
Maintained: Buy
Price Target: $135 → $140
Current: $121.69
Upside: +15.05%
Apr 30, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $15.35
Upside: +23.78%
Apr 30, 2026
Maintained: Hold
Price Target: $80 → $65
Current: $63.81
Upside: +1.86%
Apr 26, 2026
Reiterated: Buy
Price Target: $136 → $108
Current: $90.78
Upside: +18.97%
Apr 26, 2026
Reiterated: Buy
Price Target: $285
Current: $228.17
Upside: +24.91%
Apr 7, 2026
Maintained: Buy
Price Target: $198
Current: $149.56
Upside: +32.39%
May 23, 2025
Maintained: Hold
Price Target: $4.15
Current: $1.62
Upside: n/a
Nov 16, 2022
Maintained: Hold
Price Target: CHF 52.88 → CHF 54.46
Current: $52.08
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $194.32
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $25.69
Upside: n/a
Aug 8, 2014
Rated: Hold
Price Target: $24
Current: $178.90
Upside: n/a